{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Angiotensin-converting enzyme", "Hypertension in pregnancy", "Phytotherapy", "Preeclampsia", "Pregnancy"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35675745", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "05"}], "Language": ["eng"], "ELocationID": ["100562", "10.1016/j.jaim.2022.100562", "S0975-9476(22)00021-3"], "Journal": {"ISSN": "0975-9476", "JournalIssue": {"Volume": "13", "Issue": "2", "PubDate": {"Year": "2022", "Season": "Apr-Jun"}}, "Title": "Journal of Ayurveda and integrative medicine", "ISOAbbreviation": "J Ayurveda Integr Med"}, "ArticleTitle": "South African medicinal plants displaying angiotensin-converting enzyme inhibition: Potential use in the management of preeclampsia.", "Pagination": {"StartPage": "100562", "MedlinePgn": "100562"}, "Abstract": {"AbstractText": ["In resource-limited settings, such as South Africa, hypertensive disorders of pregnancy such as preeclampsia, is the most common direct cause of maternal deaths. Current management strategies of preeclampsia primarily involve the use of pharmaceutical drugs, which are frequently associated with undesirable side-effects. Moreover, these drugs are often not easily accessible due to financial and economic constraints. Consequently, many patients rely on traditional medicine obtained from medicinal plants to manage health-related conditions. Angiotensin-converting enzyme inhibitors are widely used drugs for the management of preeclampsia. This narrative review aims to highlight the use of indigenous medicinal plants from South Africa with Angiotensin-converting enzyme inhibitory activity whilst also evaluating their potential use in the treatment of hypertension in pregnancy. This information will influence traditional healers and sangomas in their patient management. Furthermore, the antihypertensive potential of these plants will be unraveled thus facilitating the development of new naturally occurring pharmaceutical products to reduce maternal and neonatal mortality and morbidity."], "CopyrightInformation": "Copyright \u00a9 2022 The Authors. Published by Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Science, Faculty of Health Sciences, Durban University of Technology, Durban, South Africa."}], "LastName": "Reddy", "ForeName": "Rebecca", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Catalysis and Peptide Research Unit, Discipline of Pharmaceutical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa."}], "LastName": "Baijnath", "ForeName": "Sooraj", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Chemistry and Physics, University of KwaZulu-Natal, Durban, South Africa."}], "LastName": "Moodley", "ForeName": "Roshila", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Women's Health and HIV Research Group, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa."}], "LastName": "Moodley", "ForeName": "Jagidesa", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Discipline of Optics and Imaging, Doris Duke Medical Research Institute, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, 4001, South Africa."}], "LastName": "Naicker", "ForeName": "Thajasvarie", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Science, Faculty of Health Sciences, Durban University of Technology, Durban, South Africa. Electronic address: nalinip@dut.ac.za."}], "LastName": "Govender", "ForeName": "Nalini", "Initials": "N"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Ayurveda Integr Med", "NlmUniqueID": "101551404", "ISSNLinking": "0975-9476"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Rana S., Lemoine E., Granger J.P., Karumanchi S.A. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094\u20131112.", "ArticleIdList": ["30920918"]}, {"Citation": "Fasanya H.O., Hsiao C.J., Armstrong-Sylvester K.R., Beal S.G. A\u00a0critical review on the use of race in understanding racial disparities in preeclampsia. J\u00a0Appl Lab Med. 2021;6(1):247\u2013256.", "ArticleIdList": ["PMC8516080", "33227139"]}, {"Citation": "Organization WH Maternal mortality ratio 2019. https://www.who.int/news-room/fact-sheets/detail/maternal-mortality Available from:"}, {"Citation": "Moodley J., Fawcus S., Pattinson R., editors. 21 years of confidential enquiries into maternal deaths in South Africa: reflections on maternal death assessments. Obstetrics and Gynaecology Forum. House Publications; 2020."}, {"Citation": "Brown M.A., Magee L.A., Kenny L.C., Karumanchi S.A., McCarthy F.P., Saito S., et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72(1):24\u201343.", "ArticleIdList": ["29899139"]}, {"Citation": "Stamilio D.M., Beckham A.J., Boggess K.A., Jelovsek J.E., Venkatesh K.K. Risk factors for postpartum readmission for preeclampsia or hypertension before delivery discharge among low-risk women: a case-control study. Am J Obstet Gynecol MFM. 2021;3(3)", "ArticleIdList": ["33493701"]}, {"Citation": "Ueki N., Takeda S., Koya D., Kanasaki K. The relevance of the Renin-Angiotensin system in the development of drugs to combat preeclampsia. International journal of endocrinology. 2015;2015", "ArticleIdList": ["PMC4426891", "26000015"]}, {"Citation": "Brown C.M., Garovic V.D. Mechanisms and management of hypertension in pregnant women. Curr Hypertens Rep. 2011;13(5):338.", "ArticleIdList": ["PMC3746761", "21656283"]}, {"Citation": "Colafella K.M.M., Bov\u00e9e D.M., Danser A.J. The renin-angiotensin-aldosterone system and its therapeutic targets. Exp Eye Res. 2019;186", "ArticleIdList": ["31129252"]}, {"Citation": "Agrawal A., Wenger N.K. Hypertension during pregnancy. Curr Hypertens Rep. 2020;22(9):1\u20139.", "ArticleIdList": ["32852628"]}, {"Citation": "Lindheimer M.D., Taler S.J., Cunningham F.G. Hypertension in pregnancy. J\u00a0Am Soc Hypertens. 2008;2(6):484\u2013494.", "ArticleIdList": ["20409930"]}, {"Citation": "Baekeland F., Lundwall L. Effects of methyldopa on sleep patterns in man. Electroencephalogr Clin Neurophysiol. 1971;31(3):269\u2013273.", "ArticleIdList": ["4105874"]}, {"Citation": "Horwitz D., Pettinger W.A., Orvis H., Thomas R.E., Sjoerdsma A. Effects of methyldopa in fifty hypertensive patients. Clin Pharmacol Therapeut. 1967;8(2):224\u2013234.", "ArticleIdList": ["6021583"]}, {"Citation": "Michelson E.L., Frishman W.H., Lewis J.E., Edwards W.T., Flanigan W.J., Bloomfield S.S., et al. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension. Am J Med. 1983;75(4):68\u201380.", "ArticleIdList": ["6356901"]}, {"Citation": "Vigil-De Gracia P., Lasso M., Ruiz E., Vega-Malek J.C., de Mena F.T., L\u00f3pez J.C. Severe hypertension in pregnancy: hydralazine or labetalol: a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2006;128(1\u20132):157\u2013162.", "ArticleIdList": ["16621226"]}, {"Citation": "Heida K.Y., Zeeman G.G., Van Veen T.R., Hulzebos C.V. Neonatal side effects of maternal labetalol treatment in severe preeclampsia. Early Hum Dev. 2012;88(7):503\u2013507.", "ArticleIdList": ["22525036"]}, {"Citation": "Ben-Ami M., Giladi Y., Shalev E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol. 1994;101(3):262\u2013263.", "ArticleIdList": ["8193107"]}, {"Citation": "Pickkers P., Dormans T.P., Russel F.G., Hughes A.D., Thien T., Schaper N., et al. Direct vascular effects of furosemide in humans. Circulation. 1997;96(6):1847\u20131852.", "ArticleIdList": ["9323071"]}, {"Citation": "Magee L.A., Cham C., Waterman E.J., Ohlsson A., Von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003;327(7421):955.", "ArticleIdList": ["PMC259162", "14576246"]}, {"Citation": "Guignard J. Persist anuria in a neonate: a side effect of captopril? Int J Pediatr Nephrol. 1981;2:133."}, {"Citation": "Krcft-Jais C., Plouin P.F., Tchobroutsky C., Boutroy M.J. Angiotensin-converting enzyme inhibitors during pregnancy: a survey of 22 patients given captopril and nine given enalapril. BJOG An Int J Obstet Gynaecol. 1988;95(4):420\u2013422.", "ArticleIdList": ["2838069"]}, {"Citation": "Briggs G.G., Nageotte M.P. Fatal fetal outcome with the combined use of valsartan and atenolol. Ann Pharmacother. 2001;35(7\u20138):859\u2013861.", "ArticleIdList": ["11485133"]}, {"Citation": "Brown C.M., Garovic V.D. Drug treatment of hypertension in pregnancy. Drugs. 2014;74(3):283\u2013296.", "ArticleIdList": ["PMC4558097", "24554373"]}, {"Citation": "Karthikeyan V.J., Ferner R.E., Baghdadi S., Lane D.A., Lip G.Y., Beevers D.G. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies. J\u00a0Hypertens. 2011;29(2):396\u2013399.", "ArticleIdList": ["21119533"]}, {"Citation": "Bateman B.T., Patorno E., Desai R.J., Seely E.W., Mogun H., Dejene S.Z., et al. Angiotensin-converting enzyme inhibitors and the risk of congenital malformations. Obstet Gynecol. 2017;129(1):174.", "ArticleIdList": ["PMC5177460", "27926639"]}, {"Citation": "Cooper W.O., Hernandez-Diaz S., Arbogast P.G., Dudley J.A., Dyer S., Gideon P.S., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N\u00a0Engl J Med. 2006;354(23):2443\u20132451.", "ArticleIdList": ["16760444"]}, {"Citation": "Diav-Citrin O., Shechtman S., Halberstadt Y., Finkel-Pekarsky V., Wajnberg R., Arnon J., et al. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reprod Toxicol. 2011;31(4):540\u2013545.", "ArticleIdList": ["21338666"]}, {"Citation": "Porta M., Hainer J., Jansson S.-O., Malm A., Bilous R., Chaturvedi N., et al. Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled DIabetic REtinopathy Candesartan Trials. Diabetologia. 2011;54(6):1298\u20131303.", "ArticleIdList": ["21225239"]}, {"Citation": "Lennest\u00e5l R., Olausson P.O., K\u00e4ll\u00e9n B. Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol. 2009;65(6):615\u2013625.", "ArticleIdList": ["19198819"]}, {"Citation": "Sullivan S.D., Umans J.G., Ratner R. Hypertension complicating diabetic pregnancies: pathophysiology, management, and controversies. J\u00a0Clin Hypertens. 2011;13(4):275\u2013284.", "ArticleIdList": ["PMC8673181", "21466626"]}, {"Citation": "Bullo M., Tschumi S., Bucher B.S., Bianchetti M.G., Simonetti G.D. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension. 2012;60(2):444\u2013450.", "ArticleIdList": ["22753220"]}, {"Citation": "Hanssens M., Keirse M., Vankelecom F., Van Assche F.A. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet Gynecol. 1991;78(1):128\u2013135.", "ArticleIdList": ["2047053"]}, {"Citation": "Dar R.A., Shahnawaz M., Qazi P.H. General overview of medicinal plants: a review. J\u00a0Phytopharmacol. 2017;6(6):349\u2013351."}, {"Citation": "Balogun F.O., Ashafa A.O.T. A\u00a0review of plants used in South African Traditional Medicine for the management and treatment of hypertension. Planta Med. 2019;85(4):312\u2013334.", "ArticleIdList": ["30477041"]}, {"Citation": "Romano B., Lucariello G., Capasso R. Multidisciplinary Digital Publishing Institute; 2021. Topical Collection \u201cpharmacology of medicinal plants\u201d.", "ArticleIdList": ["PMC7828774", "33466709"]}, {"Citation": "Van Wyk B.-E., Gericke N. Briza publications; 2000. People\u2019s plants: a guide to useful plants of Southern Africa."}, {"Citation": "Van Wyk B.-E., Bv Oudtshoorn, Gericke N. Briza; 1997. Medicinal plants of South Africa."}, {"Citation": "Hosseinzadeh S., Jafarikukhdan A., Hosseini A., Armand R. The application of medicinal plants in traditional and modern medicine: a review of Thymus vulgaris. Int J Clin Med. 2015;6(9):635."}, {"Citation": "Cock I., Selesho M., Van Vuuren S. A\u00a0review of the traditional use of southern African medicinal plants for the treatment of selected parasite infections affecting humans. J\u00a0Ethnopharmacol. 2018;220:250\u2013264.", "ArticleIdList": ["29621583"]}, {"Citation": "Duncan A.C., J\u00e4ger A.K., van Staden J. Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors. J\u00a0Ethnopharmacol. 1999;68(1\u20133):63\u201370.", "ArticleIdList": ["10624863"]}, {"Citation": "Ramesar S., Baijnath H., Govender T., Mackraj I. Angiotensin I-converting enzyme inhibitor activity of nutritive plants in KwaZulu-Natal. J\u00a0Med Food. 2008;11(2):331\u2013336.", "ArticleIdList": ["18598177"]}, {"Citation": "Sarker U., Oba S. Nutraceuticals, antioxidant pigments, and phytochemicals in the leaves of Amaranthus spinosus and Amaranthus viridis weedy species. Sci Rep. 2019;9(1):1\u201310.", "ArticleIdList": ["PMC6938518", "31892700"]}, {"Citation": "Gopal T., Megha G., Chamundeeswari D., Reddy C.U. Phytochemical and pharmacological studies on whole plant of Asystasia gangetica. Indian J Res Pharm Biotechnol. 2013;1(3):365."}, {"Citation": "Senthilkumar A., Venkatesalu V. Phytochemical analysis and antibacterial activity of the essential oil of Clausena anisata (Willd.) Hook. f. ex Benth. Int J Integr Biol. 2009;5(2):116\u2013120."}, {"Citation": "Goldblatt P., Manning J.C. Two new subspecies of Dietes (Iridaceae: iridoideae), Dietes iridioides subsp. angolensis from Angola and Dietes bicolor subsp. armeniaca from eastern South Africa, with notes and range extensions for Dietes butcheriana and Dietes iridioides. Bothalia-African Biodivers Conserv. 2015;45(1):1\u20136."}, {"Citation": "Reid K., J\u00e4ger A., Van Staden J. Pharmacological and phytochemical properties of Dombeya rotundifolia. South Afr J Bot. 2001;67(2):349\u2013353."}, {"Citation": "Mhlongo N.Y., Naidu K.S.B., Himakar R.K., Cheriti A., Govender P. Phytochemical screening, antioxidant and antimicrobial efficacy of Protorhus longifolia (Bernh. Ex C. krauss) Engl. (Anacardiaceae) seed extracts. Curr Trends Biotechnol Pharm. 2018;12(2):128\u2013138."}, {"Citation": "Ojewole J.A. Anticonvulsant effect of Rhus chirindensis (Baker F.)(Anacardiaceae) stem-bark aqueous extract in mice. J\u00a0Ethnopharmacol. 2008;117(1):130\u2013135.", "ArticleIdList": ["18337032"]}, {"Citation": "Russo D., Miglionico R., Carmosino M., Bisaccia F., Andrade P.B., Valent\u00e3o P., et al. A\u00a0comparative study on phytochemical profiles and biological activities of Sclerocarya birrea (A. Rich.) Hochst leaf and bark extracts. Int J Mol Sci. 2018;19(1):186.", "ArticleIdList": ["PMC5796135", "29316691"]}, {"Citation": "Meurer-Grimes B., Stevenson D.W. The biflavones of the Cycadales revisited: biflavones in Stangeria eriopus, Chigua restrepoi and 32 other species of Cycadales. Biochem Systemat Ecol. 1994;22(6):595\u2013603."}, {"Citation": "Davids D., Gibson D., Johnson Q. Ethnobotanical survey of medicinal plants used to manage high blood pressure and type 2 diabetes mellitus in Bitterfontein, Western Cape Province, South Africa. J\u00a0Ethnopharmacol. 2016;194:755\u2013766.", "ArticleIdList": ["27780752"]}, {"Citation": "Olorunnisola O., Bradley G., Afolayan A. Ethnobotanical information on plants used for the management of cardiovascular diseases in Nkonkobe Municipality, South Africa. J\u00a0Med Plants Res. 2011;5(17):4256\u20134260."}, {"Citation": "Takaidza S., Mtunzi F., Pillay M. Analysis of the phytochemical contents and antioxidant activities of crude extracts from Tulbaghia species. J\u00a0Tradit Chin Med. 2018;38(2):272\u2013279.", "ArticleIdList": ["32186066"]}, {"Citation": "Breyer-Brandwijk M.G. The medicinal and poisonous plants of southern and eastern africa being an account of their medicinal and other uses, chemical composition, pharmacological effects and toxicology in man and animal. The medicinal and poisonous plants of southern and eastern africa being an account of their medicinal and other uses, chemical composition, pharmacological effects and toxicology in man and animal. Edn 2. 1962."}, {"Citation": "Sagesaka-Mitane Y., Sugiura T., Miwa Y., Yamaguchi K., Kyuki K. Effect of tea-leaf saponin on blood pressure of spontaneously hypertensive rats. Yakugaku Zasshi: J Pharm Soc Jpn. 1996;116(5):388\u2013395.", "ArticleIdList": ["9019528"]}, {"Citation": "Takahashi S., Hori K., Shinbo M., Hiwatashi K., Gotoh T., Yamada S. Isolation of human renin inhibitor from soybean: soyasaponin I is the novel human renin inhibitor in soybean. Biosci Biotechnol Biochem. 2008", "ArticleIdList": ["19060406"]}, {"Citation": "Mugabo P., Raji I.A. Effects of aqueous leaf extract of Asystasia gangetica on the blood pressure and heart rate in male spontaneously hypertensive Wistar rats. BMC Compl Alternative Med. 2013;13(1):1\u20137.", "ArticleIdList": ["PMC3815069", "24160568"]}, {"Citation": "Marchesi C., Paradis P., Schiffrin E.L. Role of the renin\u2013angiotensin system in vascular inflammation. Trends Pharmacol Sci. 2008;29(7):367\u2013374.", "ArticleIdList": ["18579222"]}, {"Citation": "Lechaba N.M.T., Schutte P.J., Hay L., B\u00f6hmer L., Govender M.M. The effects of an aqueous leaf extract of Clausena anisata (Willd.) Hook. f. ex Benth. on blood pressure, urine output, angiotensin II levels and cardiac parameters in spontaneously hypertensive rats. J\u00a0Med Plants Res. 2016;10(28):425\u2013434."}, {"Citation": "Chakraborty A., Chowdhury B., Bhattacharyya P. Clausenol and clausenine\u2014two carbazole alkaloids from Clausena anisata. Phytochemistry. 1995;40(1):295\u2013298.", "ArticleIdList": ["7546552"]}, {"Citation": "Gilani A., Shaheen F., Saeed S., Bibi S., Sadiq M., Faizi S. Hypotensive action of coumarin glycosides from Daucus carota. Phytomedicine. 2000;7(5):423\u2013426.", "ArticleIdList": ["11081994"]}, {"Citation": "Pujol J. Natural Healers Foundation; 1990. Natur africa: jean pujol."}, {"Citation": "Moagi L.E., Schutte P., Steinmann C. University of Limpopo (Medunsa Campus); 2013. Cardiovascular effects of dietes iridioides in spontaneous hypertensive rats (SHR)"}, {"Citation": "Wilcox C.S. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol. 2005;289(4):R913\u2013R935.", "ArticleIdList": ["16183628"]}, {"Citation": "Ojewole J.A. Vasorelaxant and hypotensive effects of Sclerocarya birrea (A Rich) Hochst (Anacardiaceae) stem bark aqueous extract in rats: cardiovascular topic. Cardiovasc J South Afr. 2006;17(3):117\u2013123.", "ArticleIdList": ["16807627"]}, {"Citation": "Gondwe M., Kamadyaapa D., Tufts M., Chuturgoon A., Musabayane C. Sclerocarya birrea [(A. Rich.) Hochst.][Anacardiaceae] stem-bark ethanolic extract (SBE) modulates blood glucose, glomerular filtration rate (GFR) and mean arterial blood pressure (MAP) of STZ-induced diabetic rats. Phytomedicine. 2008;15(9):699\u2013709.", "ArticleIdList": ["18406590"]}, {"Citation": "Masoko P., Mmushi T., Mogashoa M., Mokgotho M., Mampuru L., Howard R. In\u00a0vitro evaluation of the antifungal activity of Sclerocarya birrea extracts against pathogenic yeasts. Afr J Biotechnol. 2008;7(20)"}, {"Citation": "Braca A., Politi M., Sanogo R., Sanou H., Morelli I., Pizza C., et al. Chemical composition and antioxidant activity of phenolic compounds from wild and cultivated Sclerocarya birrea (Anacardiaceae) leaves. J\u00a0Agric Food Chem. 2003;51(23):6689\u20136695.", "ArticleIdList": ["14582961"]}, {"Citation": "Mackraj I., Ramesar S. Wiley Online Library; 2007. ACE inhibitor activity of nutritive plants in Kwa-Zulu Natal."}, {"Citation": "Olorunnisola O., Bradley G., Afolayan A. Antioxidant properties and cytotoxicity evaluation of methanolic extract of dried and fresh rhizomes of Tulbaghia violacea. Afr J Pharm Pharmacol. 2011;5(22):2490\u20132497."}, {"Citation": "Olorunnisola O.S., Bradley G., Afolayan A.J. Protective effect of Tulbaghia violacea Harv. on aortic pathology, tissue antioxidant enzymes and liver damage in diet-induced atherosclerotic rats. Int J Mol Sci. 2012;13(10):12747\u201312760.", "ArticleIdList": ["PMC3497297", "23202923"]}, {"Citation": "Moodley K., Joseph K., Naidoo Y., Islam S., Mackraj I. Antioxidant, antidiabetic and hypolipidemic effects of Tulbaghia violacea Harv.(wild garlic) rhizome methanolic extract in a diabetic rat model. BMC Compl Alternative Med. 2015;15(1):408.", "ArticleIdList": ["PMC4647322", "26577219"]}, {"Citation": "Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355(9198):134\u2013138.", "ArticleIdList": ["10675182"]}, {"Citation": "Eriamiatoe I., Edema M., Eriamiatoe T., Okpara G. Chemical constituents and pharmacological use OF asystasia gangetica (Chinese violet) as an anti-ulcer plant. J\u00a0Chem Soc Niger. 2020;45(2)"}, {"Citation": "Irungu B.N., Mbabu M.J., Kiboi D.M., Moindi E., Kinyua J., Mwirichia R.K. 2012. In\u00a0vivo antimalarial and acute toxicity properties of hexane and chloroform extracts from Clausena anisata (Willd.) Benth."}, {"Citation": "Muhammad S., Hassan L., Dangoggo S., Hassan S., Umar K., Aliyu R. Acute and subchronic toxicity studies of kernel extract of Sclerocarya birrea in rats. Sci World J. 2011;6(3):11\u201314."}, {"Citation": "Olorunnisola O., Bradley G., Afolayan A. Acute and sub-chronic toxicity studies of methanolic extract of Tulbaghia violacea rhizomes in Wistar rats. Afr J Biotechnol. 2012;11(83):14934\u201314940."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "9"}, {"Year": "2022", "Month": "3", "Day": "1"}, {"Year": "2022", "Month": "3", "Day": "4"}, {"Year": "2022", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "9", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "8", "Hour": "18", "Minute": "16"}, {"Year": "2022", "Month": "6", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35675745", "PMC9178479", "10.1016/j.jaim.2022.100562", "S0975-9476(22)00021-3"]}}], "PubmedBookArticle": []}